AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tempest Therapeutics, Inc. Director's Dealing 2016

Jun 6, 2016

Director's Dealing

Opens in your device viewer

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2016-06-02

Reporting Person: CAPELLO JEFFREY D (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-02	Stock Option (right to buy)	$7.38	A	12000	Acquired	2026-06-02	Common Stock (12000)	Direct

F1: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 2, 2016.